Study: NCT01235728

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 2% Cream
Description: Approximately 3 to 5 mg of MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0873 vehicle (placebo) Cream
Description: Approximately 3 to 5 mg matching placebo to MK-0873 2% cream per cm\^2 of body area in 2 divided applications per day for 28 days. The maximum area for one treatment will be approximately 5% of body surface area.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol Cream
Description: Approximately 3 to 5 mg of Calcitriol 0.0003% (3 µg/g) per cm\^2 of body area once daily for 28 days. The maximum area for one treatment will be approximately 5% of body surface area